Medtronic PLC vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while iShares 1 3 Year Treasury Bond ETF trades at $81.2 (market cap $26.68B). The key difference: Medtronic PLC is far larger — about 4.2× iShares 1 3 Year Treasury Bond ETF's market cap, and Medtronic PLC pays a 3.28% dividend while iShares 1 3 Year Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and iShares 1 3 Year Treasury Bond ETF for 63 Days on average.
| MDT | SHY | |
|---|---|---|
Market Cap | $112.24B | $26.68B |
Volume | 105,663,236 | 4,077,691 |
Sector | Health | Fixed Income |
52-Week High | $105.35 | $83.18 |
52-Week Low | $73.75 | $81.05 |
Typical Hold Time | 63 Days | 63 Days |
Enterprise Value | $131.58B | — |
Dividend Yield | 3.28% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $88.48, up 3.47% today, with a bullish analyst consensus and a $97.80 price target. The stock shows strong fundamentals with revenue growth to $33.54B in 2025 and a net income margin of 13.93%. Recent earnings beats and a 49-year dividend growth streak highlight operational strength, though technical indicators signal a near-term bearish trend with key support at $87.
MDT presents a compelling long-term investment with stable profitability and dividend reliability, but faces risks from debt increases and competitive pressures. Upside potential exists if the company maintains earnings momentum and executes on growth initiatives, while volatility may persist due to market sentiment shifts.
SHY trades at $81.20 with minimal daily movement (+0.05%), showing stability amid broader bond market volatility. Technical indicators signal a bearish trend with moving averages pointing downward, though oscillators remain neutral. Recent dividend payments of $0.24-$0.25 per share provide consistent income, but key financial ratios are unavailable for fundamental assessment. The ETF faces headwinds from rising Treasury yields and persistent inflation pressures affecting fixed income markets.
Outlook remains cautious as SHY navigates a challenging interest rate environment. The fund benefits from short-duration focus during Fed tightening cycles but faces pressure from bond market selloffs. Investment opportunity lies in yield advantage over cash, while risks include further rate hikes and prolonged inflation. Institutional sentiment appears mixed given conflicting technical signals and macroeconomic uncertainty.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →